US-based biotechnology companies Exelixis and MSD have partnered to assess the potential of combining their respective cancer ...

Drug makers Exelixis, Inc. (EXEL) and Merck & Co Inc.(MRK) announced Monday that they have entered into a clinical development ...

Merck & Co has extended its range of cancer medicines in the US after claiming FDA approval for Welireg – a drug it acquired as part of its $2.2 billion takeover of Peloton Therapeutics in 2019 ...

Alameda, California Tuesday, October 15, 2024, 14:00 Hrs [IST] ...

Exelixis, Inc. EXEL entered into a clinical development collaboration agreement with pharma giant Merck MRK to advance the ...

Patients in England and Wales with a rare genetic disorder will soon be able to access treatment with MSD's Welireg via the NHS, nearly a year after their counterparts in Scotland. In final draft ...

Exelixis, an Alameda, Calif., oncology company, and Rahway, N.J., drugmaker Merck said they also plan a Phase 1/2 trial and two Phase 3 studies of zanzalintinib in combination with Merck's Welireg in ...

In the 1990s, China began sending pandas to foreign zoos to be bred, in the hope that future generations could be released into the wild. It hasn’t gone as planned. By Mara Hvistendahl and Joy ...

Oct. 3, 2024 — Scientists were recently surprised to find that the natural community of zooplankton -- tiny, aquatic animals known to graze on bacteria -- present in freshwater and saltwater do ...

Oct. 15, 2024 — Researchers have discovered seven new species of tree frogs that make otherworldly calls in the rainforests of Madagascar. Their strange, ... Tube Sock-Like Skunk Covers More ...

5, 2024 /CNW/ - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that it has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) ...

Exelixis (EXEL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Stephen Willey ...